Michael B. McNulty
Keine laufenden Positionen mehr
Karriereverlauf von Michael B. McNulty
Ehemalige bekannte Positionen von Michael B. McNulty
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Direktor/Vorstandsmitglied | 25.05.2009 | 29.12.2010 |
RESPONSE GENETICS, INC | Geschäftsführer | 12.07.2010 | 26.10.2010 |
AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | 01.07.2010 | 01.07.2010 |
Berkeley HeartLab, Inc.
Berkeley HeartLab, Inc. Medical/Nursing ServicesHealth Services Berkeley HeartLab Inc. operates as a cardiovascular healthcare company. It provides cardiovascular disease management tools and services, with focus on the secondary prevention market. The company was founded by Robert H. Superko in 1995 and is headquartered in CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 | 01.01.2004 |
General Counsel | 01.01.2004 | 01.01.2004 | |
SmithKline Beecham Clinical Laboratories
SmithKline Beecham Clinical Laboratories Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, SmithKline Beecham Clinical Laboratories is a British company that provides diagnostic services, testing, and information. The company is based in Heston, UK. | Corporate Officer/Principal | - | - |
Ausbildung von Michael B. McNulty
San Jose State University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Vereinigtes Königreich | 2 |
Operativ
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Chief Operating Officer | 1 |
Sektoral
Health Technology | 3 |
Commercial Services | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
RESPONSE GENETICS, INC | Health Technology |
AGILENT TECHNOLOGIES, INC. | Commercial Services |
Private Unternehmen | 3 |
---|---|
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Health Technology |
SmithKline Beecham Clinical Laboratories
SmithKline Beecham Clinical Laboratories Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, SmithKline Beecham Clinical Laboratories is a British company that provides diagnostic services, testing, and information. The company is based in Heston, UK. | Commercial Services |
Berkeley HeartLab, Inc.
Berkeley HeartLab, Inc. Medical/Nursing ServicesHealth Services Berkeley HeartLab Inc. operates as a cardiovascular healthcare company. It provides cardiovascular disease management tools and services, with focus on the secondary prevention market. The company was founded by Robert H. Superko in 1995 and is headquartered in CA. | Health Services |
- Börse
- Insiders
- Michael B. McNulty
- Erfahrung